News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM
mdanderson.org
May 19, 2025, 15:26

New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM

MD Anderson Cancer Center shared a post on LinkedIn:

“New research from MD Anderson shows that teclistamab, a bispecific antibody, is safe and effective for older patients with relapsed/refractory multiple myeloma. In a study led by our Dr. Oren Pasvolsky and Dr. Hans Lee, patients ages 75 and older experienced similar safety and better progression-free survival compared to younger patients. These findings may help expand access to this promising therapy for older adults.”

Read further.

More posts featuring MD Anderson Cancer Center.

cancer Hans Lee MD Anderson Cancer Center MM multiple myeloma OncoDaily Oncology Oren Pasvolsky RRMM teclistamab
Special Coverage
Insight
May 19, 2025, 15:26
New Research from MD Anderson Shows that Teclistamab is Safe and Effective for Older Patients with RRMM
Blog
May 19, 2025, 15:25
AACR Opens Nominations for Lifetime Achievement Award in Cancer Research
Blog
May 19, 2025, 15:17
Registration is Open for the Virtual Journal Club on NETTER-2 and KEYNOTE-826 Cancer Studies - ESMO
Blog
May 19, 2025, 14:20
It’s Pink Monday: Your Reminder to Prioritize Your Health - Medicaid Cancer Foundation
Blog
May 19, 2025, 14:10
Debra Patt: Wellbeing and Experience Initiatives at COA Conference
Blog
May 19, 2025, 14:00
Valsamo Anagnostou: Our Blog Content Is Growing with Simplified Science and Educational Videos
Blog
May 19, 2025, 13:59
Vincent Rajkumar: How this most Notorious Drug on the Planet made an Incredible Comeback
Opinion
May 19, 2025, 13:41
New Paper Alert: NO LIMIT Trial. First-Line Nivolumab Plus Low-Dose Ipilimumab in MSI-High Advanced Gastric and GEJ Cancer
Insight
May 19, 2025, 13:27
E. Shyam P. Reddy: How Four Small DNA Changes Helped Shape the Human Brain
Insight
May 19, 2025, 13:02
Amol Akhade: New Development Therapeutic Data to Watch at ASCO 2025
Blog
May 19, 2025, 12:48
Narjust Florez: Adventures with Stephen Liu in Mexico City
Blog
May 19, 2025, 11:41
Amol Akhade: Top 10 Breast Cancer Trials to Watch at ASCO25